Fernanda de Lima Ferreira

pharmacovigilance drug safety pharmacoepidemiology post-marketing surveillance adverse events epidemiologic studies confounding variables epidemiology audits inspections fda volume 9a cfr-21 ema serious adverse event narratives narratives icsr sae regulations regulatory pharmaceutical anvisa ich pbrer